ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HCWB vs PRFX // REVENUE GROWTH (YOY)

HCW Biologics Inc. (NASDAQ) VS. PRF Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: HCWB 2 — PRFX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCWB VS. PRFX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HCWB PRFX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 20.00% -30.00% +50.00 HCWB /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 PRFX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.3 36.6 -5.30 PRFX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.6M $2.6M $13.8K HCWB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HCWB REV PRFX REV HCWB GROSS % PRFX GROSS % HCWB FCF PRFX FCF
FY 2025 $54.2K $17.0K 20.0% -50.0% -$13.4M -$4.0M
FY 2024 $2.6M $0 37.4% — -$14.5M -$12.6M
FY 2023 $0 $0 — — -$22.5M -$6.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCWB // BETA —
PRFX // BETA —